Exec Chat: How Verb Surgical Will Deliver On Surgery 4.0

The digital revolution looks to be sweeping across different industries, which are now fully embracing technologies around connectivity, big data and artificial intelligence to drive innovation and better outcomes. Health care seems to have come late to this party, but changes are happening as medtech companies make a concerted effort to incorporate the advanced computing capabilities needed to turn devices into smart machines that are constantly learning and adapting. Surgery is one area that will benefit from these smart technologies and Scott Huennekens, CEO of Verb Surgical, tells Medtech Insight how the J&J/Verily joint venture aims to make this happen.

Medtech Forum
Scott Huennekens discusses how Verb Surgical will deliver on Surgery 4.0 at the APAC Medtech Forum

The advent of laparoscopic surgery in the 1980s heralded a new wave of surgical techniques – dubbed "Surgery 2.0" – that allowed for safer procedures and better outcomes compared to previous-generation open surgery. Robotic devices, led by Intuitive Surgical Inc.'s da Vinci, rang in Surgery 3.0, which allowes even more precise and controlled procedures and, in turn, enables surgeons to treat ever tighter anatomical spaces and, potentially, more conditions. (Also see "Market Intel: Ever Decreasing Dimensions, Snakes And Origami: The Next-Gen Surgical Robots" - Medtech Insight, 28 February, 2017.).

Over the next few years, we will see yet another category of surgical solutions to address the limitations of today's robotics surgery and mark a new chapter – Surgery 4.0...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Surgical Procedures

More from Surgery

AAOS 2025 Orthopedic Roundup: J&J Velys UKA, Stryker Mako 4, Materialise, Canary Medical

 
• By 

At AAOS, orthopedics players showcased their latest robotic-assisted platforms, power tools, 3D printed technologies and software offerings. This article brings you highlights from interviews Medtech Insight conducted on site with representatives from J&J, Stryker, Materialise and Canary Medical.

Medtronic Presents Data To Boost Hugo’s Odds Of Getting FDA Nod

 

Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.

HRS Released Framework For Afib Center Of Excellence To Improve Outcomes Through Multidisciplinary Care

 
• By 

Medtech Insight sat down with Jared Bunch, chair of AF Center of Excellence Task Force, at HRS 2025 to discuss the newly HRS released framework for Afib Center of Excellence and get his perspective on the role industry could play to help clinicians improve patient outcomes.